XML 44 R32.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Information (Tables)
3 Months Ended
Sep. 30, 2025
Segment Information  
Schedule of results of operations and identifiable assets by industry segment

The following tables present our results of operations and identifiable assets by our three industry segments, along with amounts for Corporate/Eliminations, which are reconciled to consolidated amounts (in thousands):

Three Months Ended September 30, 2024

Optoelectronics

and

Security

Manufacturing

Healthcare

Corporate/

    

Division

    

Division

    

Division

    

Eliminations

    

Consolidated

Revenues (1):

    

    

    

External customer revenue

$

224,314

$

82,591

$

37,102

$

$

344,007

Revenue between segments

 

 

15,204

 

 

(15,204)

 

Total revenues

 

224,314

 

97,795

 

37,102

 

(15,204)

 

344,007

Cost of goods sold

 

142,300

 

76,739

 

18,243

 

(14,777)

 

222,505

Selling, general and administrative expenses

 

40,414

 

8,606

 

13,693

 

9,510

 

72,223

Research and development expenses

 

12,265

 

1,294

 

4,214

 

 

17,773

Segment income (loss) from operations

 

29,335

 

11,156

 

952

 

(9,937)

 

31,506

Restructuring and other charges

 

479

 

547

 

152

 

 

1,178

Income (loss) from operations

$

28,856

$

10,609

$

800

$

(9,937)

$

30,328

Capital expenditures

$

5,470

$

1,056

$

383

$

796

$

7,705

Depreciation and amortization

$

7,835

$

1,945

$

1,270

$

400

$

11,450

Three Months Ended September 30, 2025

Optoelectronics

and

Security

Manufacturing

Healthcare

Corporate/

    

Division

    

Division

    

Division

    

Eliminations

    

Consolidated

Revenues (1):

External customer revenue

$

254,248

$

89,632

$

40,743

$

$

384,623

Revenue between segments

 

 

19,829

 

 

(19,829)

 

Total revenues

 

254,248

 

109,461

 

40,743

 

(19,829)

 

384,623

Cost of goods sold

 

173,345

 

86,514

 

20,143

 

(18,564)

 

261,438

Selling, general and administrative expenses

 

36,109

 

8,957

 

13,060

 

8,829

 

66,955

Research and development expenses

 

13,828

 

1,237

 

5,362

 

 

20,427

Segment income (loss) from operations

 

30,966

 

12,753

 

2,178

 

(10,094)

 

35,803

Restructuring and other charges

 

2,357

 

27

 

332

 

14

 

2,730

Income (loss) from operations

$

28,609

$

12,726

$

1,846

$

(10,108)

$

33,073

Capital expenditures

$

3,562

$

1,595

$

1,207

$

664

$

7,028

Depreciation and amortization

$

6,927

$

1,681

$

1,167

$

485

$

10,260

(1)

For the three months ended September 30, 2024, one Security division customer accounted for 14% of consolidated net revenues. For the three months ended September 30, 2025, no customer accounted for 10% or more of the Company’s consolidated net revenues.

June 30, 

September 30, 

    

2025

    

2025

Assets (1) —by Segment:

Security division

$

1,608,985

$

1,637,446

Optoelectronics and Manufacturing division

 

300,405

290,831

Healthcare division

270,428

270,883

Corporate/Eliminations (2)

 

61,439

99,996

Total

$

2,241,257

$

2,299,156

(1)As of June 30, 2025 and September 30, 2025, one customer in the Security division accounted for 42% and 44% of accounts receivable, net, respectively.
(2)Eliminations in assets reflect the amount of inter-segment profits in inventory and inter-segment ROU assets under ASC 842 as of the balance sheet date. Such inter-segment profit will be realized when inventory is shipped to the external customers of the Security and Healthcare divisions.